Back
Day Range
$0.29
$0.44
52-Week Range
$0.29
$0.44
Volume
130
50D / 200D Avg
$0.44
/
$0.44
Prev Close
$0.44
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.7 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -651164.0 | 3.8 |
| Rev Growth 5Y % | -27.8 | 10.0 |
| D/E | — | 0.2 |
Key Takeaways
Revenue declined -27.80% annually over 5 years
Negative free cash flow of -158.66M
PEG of 0.05 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 52.15%
Capital intensive — 52.00% of revenue goes to capex
Growth
Revenue Growth (5Y)
-27.80%
Revenue (1Y)-79.95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net Margin-651164.00%
Op. Margin-623048.00%
Safety
Debt / Equity
N/A
Current Ratio0.22
Interest Coverage-3.35
Valuation
P/E Ratio
-3.70
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -79.95% | Revenue Growth (3Y) | -60.61% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -27.80% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 25,000.0 | Net Income (TTM) | -162.79M |
| ROE | N/A | ROA | -286.61% |
| Gross Margin | 100.00% | Operating Margin | -623048.00% |
| Net Margin | -651164.00% | Free Cash Flow (TTM) | -158.66M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.22 |
| Interest Coverage | -3.35 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.70 | P/B Ratio | N/A |
| P/S Ratio | 24076.41 | PEG Ratio | 0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 601.91M | Enterprise Value | 553.47M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25,000.0 | 124,666.0 | 161,163.0 | 125,047.0 | 91,981.0 |
| Net Income | -162.79M | -220.24M | -211.88M | -127.99M | -60.79M |
| EPS (Diluted) | -0.13 | -0.35 | -0.45 | -0.34 | -0.18 |
| Gross Profit | 25,000.0 | 22,014.0 | -89,309.0 | -107,422.0 | -480,000.0 |
| Operating Income | -155.76M | -191.84M | -223.45M | -133.27M | -53.18M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 56.80M | 188.79M | 148.19M | 87.32M | 184.36M |
| Total Liabilities | 257.87M | 264.60M | 156.98M | 17.55M | 4.16M |
| Shareholders' Equity | -201.07M | -75.81M | -8.79M | 69.77M | 180.20M |
| Total Debt | 0.0 | 141.65M | 272,982.0 | 0.0 | 150,469.0 |
| Cash & Equivalents | 48.44M | 172.47M | 133.99M | 64.90M | 157.43M |
| Current Assets | 56.80M | 188.19M | 147.80M | 87.12M | 183.97M |
| Current Liabilities | 257.87M | 64.06M | 28.16M | 17.51M | 4.14M |